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This paper reports the unusual collision-induced fragmentation of peptides having N- 
terminal glutamine. One of these glutamine-containing peptides was isolated from an endo- 
proteinase Lys-C digest of the scrapie prion protein (PrP 27-30) with the predicted sequence 
QHTVTITTK. Daughter ion mass spectra show predominant N-terminal a,, b,, and, to a 
lesser extent, c,, sequence ion series at 17 u less than the predicted masses. This is interpreted 
as arising from an ionic fragmentation that accompanies the peptide-backbone cleavage, glu- 
tamine losing ammonia to give pyroglutamic acid, a reaction that parallels the commonly 
observed solution-phase process. This behavior is less evident when strongly basic residues 
near the C-terminus cause the C-terminal fragments (G, y., and z,,) to predominate. (J Am 
Sot Mass Spectrom 1990, 1, 258-264) 
T 
e development of rapid and sensitive soft ion- 
ization methods such as fast atom bombardment 
(FAB) [l] and liquid secondary ion mass spec- 
trometry (LSIMS) [2, 31, based on kiloelectronvolt par- 
ticle bombardment of nonvolatile samples dissolved in 
a liquid matrix, has led to the widespread use of mass 
spectrometry in peptide and protein analysis [4-61. 
Protonated molecular ions are readily sputtered from 
solution for the majority of peptides in the mass range 
500-4000 u, allowing molecular masses to be deter- 
mined for peptides produced by chemical or enzymatic 
digestion of proteins. However, sputtered ions pro- 
duced by such “soft ionization” techniques normally 
have relatively little internal energy, resulting in a lim- 
ited degree of fragmentation. Although the fragmen- 
tation processes of peptides ionized by FAB or LSIMS 
have been described [5, 71, at the subnanomole level 
the spectra show either very small fragment ion peaks 
or none at all and thus yield little or no sequence in- 
formation. 
Collisional activation by either high- or low-energy 
collisions of the ions with neutral gas atoms (or a solid 
surface) can be used to increase the internal energy 
of the parent ions, leading to greatly increased frag- 
ment ion abundance, giving extensive amino acid se- 
quence information [S, 91. A major advantage of apply- 
‘Permanent address: School of Pharmacy, University of London, 
Brunswick Square, London WClN IAX, United Kingdom. 
Address reprint requests to Dr. A. M. Falick, Depz-tment of Pharmaceuti- 
cal Chemistry, University of California-San Francisco, San Francisco, CA 
94143-0446. 
@ 1990 American Society for Mass Spectromehy 
104-0305/90/$3.50 
ing the collision-induced dissociation (CID) technique 
to peptides is the considerable knowledge base con- 
cerning their fragmentation and the consequent high 
success rate for interpretation of the data. The major- 
ity of ions arise from (1) characteristic side-chain losses 
from amino acids; (2) the formation of immonium ions 
indicative of individual amino acids; (3) cleavages of 
the peptide backbone, giving N-terminal ions (a,, b,, 
and c,) and C-terminal ions (xn, y”, and z,) indicative 
of the sequence; and (4) further breakdown of the se- 
quence ions by side-chain losses (d,, vn, and w,). The 
latter ions reinforce the subsequent data and can fur- 
ther identify amino acids, in particular leucine versus 
isoleucine [lo, 111. 
The interpretation of peptide tandem mass spectra 
(MS/MS) is sufficiently straightforward to have encour- 
aged the development of computerized spectral pre- 
diction and interpretation [12, 131, but for such ap- 
proaches to be successful it is important to catalog any 
systematic divergences from the expected behavior. In 
studies of the structure of the scrapie prion protein 
isolated from the brains of hamsters [ 141, we observed 
that a peptide with an N-terminal glutamine residue 
exhibited such a divergence, and we have since estab- 
lished that this is a general phenomenon. 
Analysis of the PrPsc peptide QHTVTITTK 
(residues 185-193), which can be generated by endo- 
proteinase Lys-C digestion of the scrapie protein, is 
of considerable interest because of its possible role 
in determining scrapie incubation times. Scrapie is a 
transmissible neurodegenerative disease, and PrP% is 
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a host-encoded protein that forms a component of the 
putative infectious agent. Both hamsters and mice with 
the above PIP sequence have short incubation times, 
whereas mice with long incubation times have two 
amino acid substitutions in the PrP gene, one of which 
is a valine at amino acid 189 to give QHTWTTTK [15]. 
Long incubation times are dominant in mice that are 
heterozygous for the PrP gene, and it is of great inter- 
est to measure the respective amounts of the scrapie 
prion protein produced from each allele. Although C- 
DNA (amplified by polymerase chain reaction) indi- 
cates that the transcription of both alleles is similar 
[16], there is no information on the relative amounts 
of the two PrP forms that are converted to PrPsc during 
the course of the disease. In this laboratory, mass spec- 
trometry and MS/MS are playing an important role in 
characterizing the PrP structures and resolving ques- 
tions such as this. 
Results and Discussion 
Endoproteinase Lys-C digestion of the scrapie prion 
protein (PrP 27-30) gave a series of peptides that were 
separated by reverse-phase high-performance liquid 
chromatography (HPLC), individual fractions being 
collected for amino acid analysis and LSIMS. Two ad- 
jacent peaks in the chromatogram gave identical amino 
acid compositions, but by LSIMS the peaks due to 
their protonated molecular ions were found to dif- 
fer, being observed at m/z 1016 and 999, respectively. 
The former was identified as the mass of a peptide 
QHTVTTTTK predicted from the gene sequence for 
PrP protein [17, 181, which was also consistent with the 
amino acid analysis. The other component was iden- 
tified as the same peptide but with an N-terminal py- 
roglutamic acid residue arising from an internal nucle- 
ophilic attack with expulsion of ammonia. The reaction 
is illustrPted in Scheme 1. For proteins with N-terminal 
glutamine, this is a known in vivo posttranslational 
modification [19], but it is also a chemical process that 
occurs in peptides [20], as discussed by Carr and Bie- 
mann [21]. They state that it is most likely to occur 
in acid media, which is consistent with our experience 
that the pyro-Glu and Gln forms can be completely 
resolved by HPLC and shown to be pure, but storage 
in O.l”% trifluoroacetic acid (TFA) often results in sig- 
nificant conversion of Gln to pyro-Glu. 
This work was being carried out as part of a project 
to map the amino acid sequence and posttranslational 
modifications of the PrP proteins, and this peptide cor- 
responded to a portion of the sequence not previously 
observed. Consequently it was important to confirm 
the sequence, and this was undertaken by MS/MS. 
It was anticipated that the existence of both the N- 
terminal glutamine and N-terminal pyroglutamic acid 
peptides would aid the interpretation because the N- 
terminal fragments would exhibit 17-u shifts whereas 
the C-terminal fragments would have identical masses. 
The MS/MS spectra are shown in Figure la for pyro- 
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Scheme I
Glu-HTVITITK (MH+ peak at m/z 999.4) and in Fig- 
ure lb for QHTVmTK (MI-I+ peak at m/z 1016.4). 
The spectrum ln Figure la is relatively simple With 
few abundant peaks. Apart from peaks due to loss of 
45 u from the MH+ ion and the histidine immonium 
ion at m/z 110, the major peaks correspond to early 
members of the b, ion series arising from cleavage of 
the peptide backbone at the amide bonds with charge 
retention on the N-terminal fragments. Examples are 
b2 (m/z 249) and b3 (m/z 350). Early members of the a,, 
immonium ion series are also seen, giving somewhat 
weaker peaks for a2 (m/z 221) and G (m/z 421). The 
higher mass region shows some ion formation from 
the C-terminal fragments, but those peaks are much 
smaller despite the presence of a basic lysine residue. 
This may be explained by competition with the histi- 
dine residue close to the N-terminus. 
In some respects the spectrum of the glutamine- 
containing analogue in Figure lb is similar in that the 
N-terminal ions are predominant. However, it is more 
complex, and the anticipated mass shifts of 17 u for 
the a, and b, ions occur only partially. In addition to 
the a, and b, ions at the expected masses, there are 
associated peaks of greater abundance occurring 17 u 
lower, that is, at the same masses as the a,, and b,, ions 
from the pyroglutamic acid-containing peptide. Thus 
the spectrum in Figure lb appears to be a composite 
of the anticipated spectrum plus a substantial contri- 
bution from that of Figure la, both a, and b, ion series 
being accompanied by a, -17 and b, - 17 ion series. We 
rationalize these results as a partial loss of NH3 from 
the molecular ion and/or the N-terminal fragment ions. 
As this is a tandem spectrum, the ions observed can 
arise only from the parent ion selected in the MSI, and 
therefore there is no possibility that this phenomenon 
is due to loss of ammonia from the neutral molecule. 
Thus the internal energy imparted by collision is suf- 
ficient to break several bonds, with backbone cleavage 
being accompanied by ammonia elimination. 
For clarity, only the N-terminal ions are labeled 
in Figure lb, but a portion of this spectrum is ex- 
panded in Figure lc. This shows that C-terminal ions 
are formed and that virtually every peak can be as- 
signed as either an N-terminal or a C-terminal frag- 
ment. 
This analysis could be complicated by the fact that 
c, series ions are 17 u higher than the bn series, mak- 
ing Gln-peptide c,, - 17 ions coincident with pyre- 
Glu-peptide b, ions, as illustrated in Figure lc. The 
c ions give relatively weak peaks in most cases; how- 
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ever, to clearly establish that the loss of 17 u in the free ammo groups, and derivatization of both of these 
ions arises by elimination of ammonia from the N- basic sites could be anticipated to have relatively lit- 
terminal glutamine, we carried out an N-acetylation on tle effect on the product ion distribution in the MS/MS 
QHTVTTTTK. This example was selected because both spectrum. This spectrum, which is illustrated in Figure 
the N-terminal glutamine and C-terminal lysine have 2 and in which only the N-terminal ions are identified, 
J Am Sot Mass Spectrom 1990,1,2%?-264 MSiMS OF N-TERMINAL GLUTAMlN@ i=%lTILlES 261 
60 
J 
Mass 
shows that, as with the unacetylated compound, the 
major fragments are attributable to the b, series ions. 
There are no peaks arising from losses of 17 u, con- 
fii the role of the free N-terminal NH2 group in 
attacking the amide and eliminating NHB. Losses of 42 
and 59 u from the b, and a,, ions can be interpreted 
as arising through sequential losses of ketene and am- 
monia. 
It is noteworthy that the daughter ion spectra of 
QHTVTITTK and the related compounds illustrated 
in Figures 1 and 2 are relatively unusual in that a large 
fraction of the ion current is carried by a few peaks 
in the lower mass (~300 u) region. As stated above, 
histidine is able to stabilize the charge, but it also ap- 
pears that the repeating threonine region is relatively 
unstable and tends to fragment. 
Two further examples of peptides containing N- 
terminal glutamine were studied. Digestion of a pro- 
tein with Staphyfococcus RUWS V8 can give peptides 
without basic residues, as cleavage normally occurs 
on the C-terminal side of glutamic or aspartic acid 
residues. An example with an N-terminal glutamine is 
the undecapeptide QAGGDATENFE, which was ob- 
tained by digestion of trypsin-solubfiized rabbit cy- 
tochrome b 5 [ZZ], and for which the pyroglutamic acid- 
containing form was also isolated. The daughter ion 
mass spectra are illustrated in Figures 3a and 3b for 
the pyro-Glu and Gln peptides, respectively. There is 
no basic residue at the C-terminus, and the sequence 
peaks arise largely from the N-terminus, particularly 
the b, ions, although the C-terminal ion peaks as rep- 
resented by the y, series are of significant abundance. 
For clarity and convenience, only the a,,, b,, a,-17, and 
b, - 17 peaks are identified in Figure 3b. The majority 
of the remaining peaks can be ascribed to other frag- 
mentations as described in the introduction, plus inter- 
nal sequences. From these two spectra it is again clear 
that the a,, and b, ions for the glutamine-containing 
peptide are accompanied by a,, - 17 and b, - 17 series. 
This is most pronounced for ions of up to about five 
L 
Fii 2. CID daughter ion mass 
spectrum of the MH+ ion of N,N’- 
00 dmtylated QfrW4TKE (m/z 
X100.5). 
residues, although it is observed to some degree for 
the b, series right through to blo with no exceptions. 
Another V8 peptide with N-terminal glutamine is 
the pentapeptide QLARE obtained by digestion of col- 
icin Ia [23]. The strongly basic arginine residue near 
the C-terminus has a profound effect on its daughter 
ion mass spectrum illustrated in Figure 3, transferring 
most of the ion current to C-terminal fragments. One 
of the more abundant N-terminal fragment ions is the 
a2 fragment whose peak appears at m/z 214, which is 
accompanied by a larger a, - 17 peak at m/z 197, but 
the % peak at m/z 441 has no significant corresponding 
a,, - 17 peak at m/z 424. Similarly, the relatively mi- 
nor b, series ions show little evidence of 17-u losses. 
One further indication of loss of 17 u can be seen at 
m/t 84, the peak for the al immonium ion for pyroglu- 
tamic acid, even though the glutamine immonium ion 
peak at m/z 101 is of greater height. However, the m/z 
84 peak is normally observed in daughter ion spectra 
of peptides containing Gln regardless of its position in 
the sequence [12]. 
The N-glutamine compounds studied here gener- 
ally do not show major peaks for loss of 17 u from 
MH+ , even though these are stable ions correspond- 
ing to MH+ of the pyroglutamic acid compounds. 
(Ions corresponding to loss of 17 u can also arise by 
processes other than loss of NH, from glutamine.) It 
has been shown that the b, ions from the pentapep- 
tide Leu-enkephalin are formed by relatively complex, 
high-energy processes compared with the y,, ions (241. 
If this is a general phenomenon, it suggests that NH, 
loss from MH’ occurs only for ions of high internal 
energy, which then undergo further breakdown. Hunt 
et al. [25] noted previously that low-energy CID spec- 
tra of peptides that have amino group side chains can 
also display the usual fragment types with further loss 
of NH,. However, the findings reported here demon- 
strate that if a peptide contains N-terminal Gln, the 
N-terminal sequence ions can be dominated by the cor- 
responding ions 17 u lower. 
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Conclusions 
Tandem mass spectrometry can play an important role 
in the sequencing of peptides at the picomole level. 
In comparison with Edman sequencing, it offers the 
advantages of being able to cope with blocked N- 
terminal peptides and other posttranslational modi- 
fications such as glycosylation, phosphorylation, sul- 
fation, ester&cation, and disulfide bridge formation. 
However, successful spectra1 interpretation relies on 
being able to relate the peaks in the mass spectra to the 
amino acid sequences in a consistent and predictable 
way. Many rules for peptide fragmentation by CID are 
already understood, and we are currently building up 
a database that will further aid interpretation and pre- 
diction of spectra. 
It was already known that the presence of an N- 
terminal Gln residue in a peptide formed by digestion 
of a larger peptide or a protein could result in NH3 
elimination in solution with formation of a pyroglu- 
tamic acid residue. This can be identified by the pres- 
ence of two closely spaced chromatographic peaks, 
which give MH+ separated by 17 u by FAB or LSIMS. 
A similar effect can occur with the ions in the CID spec- 
trum, shifting the N-terminal fragment ion series by 17 
u. This effect is most pronounced for peptides that fa- 
vor N-terminal ions and is least apparent for peptides 
having basic residues at or close to the C-terminus. 
It has been noted that a similar cyclization can occur 
in peptides that contain N-terminal carboxymethylcys- 
teine in solution with the elimination of water [26]. It 
may prove interesting to determine whether a similar 
loss of 18 u from the N-terminal ions is observed under 
CID conditions. 
Experimental 
The peptides studied were obtained from enzyme di- 
gests of various proteins. QHTV’RTTK was produced 
in an endoproteinase Lys-C digest of the scrapie pro- 
tein PrP. The protein was purified and precipitated 
with ethanol as described previously [27]. The ethanol- 
precipitated protein pellets were solubilized in 6 M 
guanidine HCl, 50 mM Tris Cl (pH 8.2-8.45), and 5 mM 
EDTA. The protein was reduced with 2 mM dithio- 
threitol, alkylated with 6 mM iodoacetic acid, and 
precipitated with lo-15 volumes of ethanol overnight 
at -20 “C. The pellet was collected by centrifuga- 
tion, washed with ethanol to remove the last traces 
of guanidine HCl, resuspended in 0.1% SDS, 50 mM 
Tris Cl (pH 8.45), and 1 mM EDTA, and boiled for 1 
min. This preparation was digested overnight at 37 “C 
with 5-10 pg of endoproteinase Lys-C (sequencing 
grade, Boehringer Mannheim). The sample was incu- 
bated with 0.3 unit of PIPLC (phosphoinositol-specific 
phospholipase-C) for 3 h at 37 “(3 in the presence of 
the protease inhibitor 1 mM PMSF (cr-toluenesulfonyl 
fluoride). 
The peptides QAGGDATENFE and QLARE were 
obtained from S. uureus VS digests of trypsin- 
solubilized rabbit cytochrome b5 [22] and colicin 
Ia [23], respectively. All peptides were isolated by 
reverse-phase HPLC using either C, or Cl* columns 
(Vydac) with water-acetonitrile-0.1% TFA gradients. 
N-Acetylation of QHTVTTTTK was carried out by 
addition of 5 ILL of acetic anhydride to a dry aliquot 
(~0.5 nmol) of the peptide at room temperature. The 
reaction was allowed to proceed for 1 min, after which 
the excess reagent was removed by vacuum centrifu- 
gation. 
Tandem mass spectrometry was carried out on a 
Kratos Concept IIHH four-sector instrument equipped 
with an array detector [28]. Parent ions were gener- 
ated from a glycerol-thioglycerol matrix in an LSIMS 
source [29] employing an 18-keV Cs’ primary beam. 
The accelerating voltage in MS1 was 8 kV, and the col- 
lision energy for CID was 6 keV. The collision gas (he- 
lium) was used at the pressure sufficient to suppress 
the parent ion beam to about 30% of its initial value. 
The instrument was controlled and data were acquired 
with a DS-90 data system. The spectra shown in the 
figures are from single acquisitions using the array de- 
tector. An array acquisition consists of a single series 
of adjacent l-s exposures, each covering a mass range 
of f 2% of the central mass. The amounts of material 
used to produce the daughter ion spectra could not 
be measured accurately owing to uncertainties in the 
degree of digestion and losses resulting from isolation 
and purification; however, we estimate the amounts as 
100-200 pm01 per spectrum. 
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